
@ShahidNShah
Dr. Anmol Kapoor, an expert in precision medicine and artificial intelligence, discusses AI-driven genomic analysis, blockchain in genomics, multi-omic integration, and navigating ethical and regulatory challenges of AI-enabled personalized care.
Dr. Anmol Kapoor, founder of CardiAI and BioAro, is an expert in precision healthcare, artificial intelligence and blockchain technologies. He has filed more than 70 patents in areas ranging from AI and genomics to quantum sciences and digital health. Through his work, he aims to transform modern healthcare through personalized, precision-based approaches.
We spoke with Kapoor recently to tap his expertise and gain a deeper understanding of these emerging areas of care innovation. We discussed AI-driven genomic analysis, explored where there are strategic opportunities for the C-suite in precision medicine and discussed how distributed ledger technology can enhance data security and trust in health systems pursuing genomics.
Read on healthcareitnews.com
Continue reading at healthcareitnews.com
– The American Brain Foundation has launched a $10 million cross-disciplinary research initiative that transcends traditional research and philanthropy boundaries by bringing together …
Posted Nov 11, 2024 Digital Health Funding Biomedical Research
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Jul 10, 2025 at 12:24pm